[ad_1] The FDA approval of BioMarin’s gene therapy for hemophilia is a major win, but patient uptake could be slow. [ad_2] Source link
Tag: BMRN
New Gene Therapy Could Face Uphill Battle
[ad_1] The potential FDA approval of BioMarin’s gene therapy for hemophilia A would be a major win, but patient uptake could be slow. [ad_2] Source link